Fuelling Muscle Health in Cancer Care

Presenter(s): Carla Prado, PhD, RD, FCAHS

Date: 03 September 2025

Time: On Demand

Continuing Education Credits: Non-accredited

Patients with cancer may experience muscle loss at a rate far greater than that seen with normal ageing. This decline can result in reduced mobility, diminished quality of life, and poorer treatment outcomes. In this 48-minute on-demand webinar recording, internationally recognised nutrition expert Carla Prado, PhD, RD, FCAHS, will explain the complex and multifactorial causes of muscle loss and review the latest evidence on its impact. You will also gain insight into how nutritional interventions can prevent and reverse muscle loss in cancer and explore practical strategies to preserve muscle and support improved outcomes for patients.

Please note: This program was originally presented as a live webinar on 13 August 2025. The Q&A for the session was not recorded.

Presenter Bio(s):

Carla Prado, PhD, RD, FCAHS

Distinguished University Professor
Research Chair, Integrative Nutrition, Body Composition & Energy Metabolism
Director, Human Nutrition Research Unit
University of Alberta
Edmonton, AB, CA

Dr Carla Prado is a Distinguished University Professor and a Canada Research Chair in Integrative Nutrition, Body Composition, and Energy Metabolism (Tier 1). She is also a registered dietitian. She directs the Human Nutrition Research Unit, recognized as one of the world’s leading research and training facilities for body composition and energy metabolism assessments.

Dr Prado's research focuses on assessing nutritional status through precise measurements of body composition and energy metabolism. Her current research program investigates the prevalence and health outcomes of abnormal body composition phenotypes in patients with diverse chronic conditions. She is also developing targeted nutrition interventions to optimize body composition and improve health outcomes.

Dr Prado is an Associate Editor for two of the top journals in her field, serves on several international clinical guideline committees, and is a Fellow of the Canadian Academy of Health Sciences as well as a member of the Royal Society of Canada’s College of New Scholars, Artists, and Scientists. She was named one of Canada’s Top 40 Under 40, one of Canada’s Most Powerful Women: Top 100, and a Highly Cited Researcher by Clarivate™ (Web of Science), a recognition placing her among the top 1% of researchers globally for her significant and broad influence in the field.

 

Category